- Home
- MOB vs VVOS Comparison
MOB vs VVOS Comparison
Compare MOB & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOB
- VVOS
- Stock Information
- Founded
- MOB 2008
- VVOS 2016
- Country
- MOB Israel
- VVOS United States
- Employees
- MOB N/A
- VVOS N/A
- Industry
- MOB Real Estate Investment Trusts
- VVOS Medical Specialities
- Sector
- MOB Real Estate
- VVOS Health Care
- Exchange
- MOB Nasdaq
- VVOS Nasdaq
- Market Cap
- MOB 12.6M
- VVOS 14.8M
- IPO Year
- MOB 2022
- VVOS 2020
- Fundamental
- Price
- MOB $3.45
- VVOS $2.78
- Analyst Decision
- MOB
- VVOS Strong Buy
- Analyst Count
- MOB 0
- VVOS 2
- Target Price
- MOB N/A
- VVOS $6.10
- AVG Volume (30 Days)
- MOB 312.3K
- VVOS 153.8K
- Earning Date
- MOB 06-27-2025
- VVOS 08-13-2025
- Dividend Yield
- MOB N/A
- VVOS N/A
- EPS Growth
- MOB N/A
- VVOS N/A
- EPS
- MOB N/A
- VVOS N/A
- Revenue
- MOB $3,180,565.00
- VVOS $14,628,000.00
- Revenue This Year
- MOB N/A
- VVOS $17.40
- Revenue Next Year
- MOB N/A
- VVOS $10.78
- P/E Ratio
- MOB N/A
- VVOS N/A
- Revenue Growth
- MOB 44.98
- VVOS 9.47
- 52 Week Low
- MOB $0.76
- VVOS $1.97
- 52 Week High
- MOB $5.00
- VVOS $6.28
- Technical
- Relative Strength Index (RSI)
- MOB 72.15
- VVOS 63.20
- Support Level
- MOB $2.40
- VVOS $2.03
- Resistance Level
- MOB $2.74
- VVOS $2.28
- Average True Range (ATR)
- MOB 0.38
- VVOS 0.18
- MACD
- MOB 0.10
- VVOS 0.06
- Stochastic Oscillator
- MOB 97.22
- VVOS 100.00
About MOB Mobilicom Limited
Mobilicom Ltd is a provider of cybersecurity and smart solutions for drones, robotics & autonomous platforms. As a high-tech company, it designs, develops, and delivers smart solutions targeting global drone, robotics, and autonomous system manufacturers. Its products include OS3 Platform Software, ICE Cybersecurity Software, MCU Mesh Networking, SkyHopper Datalinks, Mobile Ground Control Stations and System Engineering Services.
About VVOS Vivos Therapeutics Inc.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.